• Prajval Birajdar
• Swapnil D Phalak
• Vishal Bodke

Abstract:- The main idea of this composition is to give all healthcare professional who are interested in BZD detoxification with an approach and clear practical information on how to administer FLU. Flumazenil is benzodiazepine receptor antagonist. Flumazenil acts as a competitive antagonist at the benzodiazepine receptor to envenom the conduct of benzodiazepines. Flumazenil does not reverse the goods of opioids. After intravenous administration flumazenil is considerably distributed in the extravascular space with an original distribution half-life of 4 to 11 twinkles and a terminal half-life of 40 to 80 twinkles. The major metabolites of flumazenil linked in unine are the de-ethylated free acid and its glucuronide conjugate. The goods of fumazenil on ventilatory response following sedation with a benzodiazepine in combination with an opioid are inconsistent

Keywords: Flumazenil; Benzodiazpeine, Antagonist,Conjugate,Half-life etc.

"A REVIEW ARTICLE ON FLUMAZENIL DRUG", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 5, page no.a457-a467, May-2023, Available :http://www.jetir.org/papers/JETIR2305063.pdf

"A REVIEW ARTICLE ON FLUMAZENIL DRUG", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 5, page no. ppa457-a467, May-2023, Available at : http://www.jetir.org/papers/JETIR2305063.pdf